BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1705535)

  • 1. Muroctasin [MDP-Lys(18)] augments the production of granulocyte colony-stimulating factor (G-CSF) from human peripheral blood mononuclear cells in vitro.
    Shimoda K; Okamura S; Kawasaki C; Omori F; Matsuguchi T; Niho Y
    Int J Immunopharmacol; 1990; 12(7):729-36. PubMed ID: 1705535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of colony-stimulating factor from macrophages by muroctasin.
    Yamaguchi F; Akahane K; Takashi T; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of macrophages by muroctasin to produce colony-stimulating factors.
    Akahane K; Yamaguchi F; Kita Y; Une T; Osada Y
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):179-83. PubMed ID: 1692219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of colony-stimulating factor and stimulation of stem cell proliferation by injection of muroctasin.
    Yamaguchi F; Akasaki M; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):980-3. PubMed ID: 3263869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of immune responses by muroctasin.
    Akasaki M
    Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of interleukin-6 from macrophages by MDP-Lys (L 18), romurtide.
    Shimoda K; Okamura S; Harada N; Omori F; Niho Y
    Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):289-96. PubMed ID: 2093210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo augmentation by muroctasin of the production of the third component of complement by murine macrophages.
    Endo N
    Arzneimittelforschung; 1988 Jul; 38(7A):993-6. PubMed ID: 3190805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
    Nagao S; Sato K; Osada Y
    Arzneimittelforschung; 1988 Jul; 38(7A):999-1002. PubMed ID: 3142490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of plasma fibronectin production in mice by muroctasin.
    Endo N; Okuda T; Osada Y; Zen-Yoji H
    Arzneimittelforschung; 1988 Jul; 38(7A):997-8. PubMed ID: 3190806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific binding sites of muroctasin on murine macrophages.
    Akasaki M; Masayasu H; Tsukada W; Takegoshi T
    Arzneimittelforschung; 1988 Jul; 38(7A):978-80. PubMed ID: 3190804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of non-specific resistance to infection by muroctasin.
    Otani T; Une T; Osada Y
    Arzneimittelforschung; 1988 Jul; 38(7A):969-76. PubMed ID: 3056426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity studies of muroctasin.
    Shimada H; Hattori C; Sato T
    Arzneimittelforschung; 1988 Jul; 38(7A):1031-3. PubMed ID: 3056424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenicity study of muroctasin.
    Yamaguchi F; Hattori H; Wagai N; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):1034-7. PubMed ID: 3190797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local tolerance of muroctasin injection in rabbits.
    Nakashima K; Jindo T; Nomura M
    Arzneimittelforschung; 1988 Jul; 38(7A):1038-9. PubMed ID: 3190798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Muroctasin, a muramyl dipeptide derivative].
    Sosnowska D; Dzierzbicka K; Myśliwski A; Kołodziejczyk AM
    Postepy Hig Med Dosw; 1992; 46(5):521-30. PubMed ID: 1298958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation by muroctasin of the serum level of the complement subcomponent C1q in mice and of its biosynthesis by cultured mouse peritoneal macrophages.
    Endo N; Okuda T; Osada Y; Zen-yoji H
    Arzneimittelforschung; 1990 Jan; 40(1):58-61. PubMed ID: 2340001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute toxicity of muroctasin in mice and dogs.
    Ono Y; Iwasaki T; Sekiguchi M; Onodera T
    Arzneimittelforschung; 1988 Jul; 38(7A):1024-7. PubMed ID: 3190795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of muroctasin in mice.
    Matsubayashi K; Takegoshi T
    Arzneimittelforschung; 1988 Jul; 38(7A):1015-8. PubMed ID: 3190793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic toxicity of muroctasin in mice.
    Ono Y; Sekiguchi M; Aihara K; Onodera T
    Arzneimittelforschung; 1988 Jul; 38(7A):1028-30. PubMed ID: 3190796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effect of muroctasin on experimental leukopenia induced by cyclophosphamide or irradiation in mice.
    Nakajima R; Ishida Y; Yamaguchi F; Otani T; Ono Y; Nomura M; Une T; Osada Y
    Arzneimittelforschung; 1988 Jul; 38(7A):986-92. PubMed ID: 3263871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.